Latest Hae Stories
A new drug, increasing use, extreme costs highlight need for integrated claims data to better identify people with the disorder, develop clinical programs that improve care, reduce costs
BRAINTREE, Mass., March 30, 2015 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) will announce its earnings for the fourth quarter and full fiscal year 2015 and will provide guidance
BRAINTREE, Mass., March 24, 2015 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that it will host its annual investor and analyst meeting on Tuesday, May 19(th) from 9:00 am to
BRAINTREE, Mass., Feb.
CARLSBAD, Calif., Feb. 24, 2015 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today positive results from a Phase 1 study with ISIS-PKK(Rx).
BRAINTREE, Mass., Dec.
BRAINTREE, Mass., Dec. 22, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Brian Concannon, President & CEO, will present at the 33(rd) Annual J.P.
BRAINTREE, Mass., Nov.
BRAINTREE, Mass., Oct.
BRAINTREE, Mass., Aug.
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.